Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer

por Levitt, N C, Propper, D J, Madhusudan, S, Braybrooke, J P, Echeta, C, te Poele, R, Davies, S L, Flanagan, E, Hickson, I D, Joel, S, Ganesan, T S
Publicado 2005

The endothelin B (ET(B)) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification

por Cemazar, M, Wilson, I, Prise, V E, Bell, K M, Hill, S A, Tozer, G M
Publicado 2005

Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma

por Brennan, P, Scélo, G, Hemminki, K, Mellemkjaer, L, Tracey, E, Andersen, A, Brewster, D H, Pukkala, E, McBride, M L, Kliewer, E V, Tonita, J M, Seow, A, Pompe-Kirn, V, Martos, C, Jonasson, J G, Colin, D, Boffetta, P
Publicado 2005

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

por Cappuzzo, F, Novello, S, De Marinis, F, Franciosi, V, Maur, M, Ceribelli, A, Lorusso, V, Barbieri, F, Castaldini, L, Crucitta, E, Marini, L, Bartolini, S, Scagliotti, G V, Crinò, L
Publicado 2005

A randomised controlled trial of nurse-managed trial conclusion following early phase cancer trial participation

por Cox, K, Wilson, E, Arthur, A, Elkan, R, Armstrong, S
Publicado 2005

A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours

por Penson, R T, Seiden, M V, Matulonis, U A, Appleman, L J, Fuller, A F, Goodman, A, Campos, S M, Clark, J W, Roche, M, Eder, J P
Publicado 2005

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

por Bengala, C, Guarneri, V, Giovannetti, E, Lencioni, M, Fontana, E, Mey, V, Fontana, A, Boggi, U, Del Chiaro, M, Danesi, R, Ricci, S, Mosca, F, Del Tacca, M, Conte, P F
Publicado 2005

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

por Qiao, G-B, Wu, Y-L, Yang, X-N, Zhong, W-Z, Xie, D, Guan, X-Y, Fischer, D, Kolberg, H-C, Kruger, S, Stuerzbecher, H-W
Publicado 2005

Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients

por Lim, S-T, Wong, E-H, Chuah, K-L, Leong, S-S, Lim, W-T, Tay, M-H, Toh, C-K, Tan, E-H
Publicado 2005

Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells

por Amit-Vazina, M, Shishodia, S, Harris, D, Van, Q, Wang, M, Weber, D, Alexanian, R, Talpaz, M, Aggarwal, B B, Estrov, Z
Publicado 2005

Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells

por Anumanthan, G, Halder, S K, Osada, H, Takahashi, T, Massion, P P, Carbone, D P, Datta, P K
Publicado 2005

Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour

por Kölby, L, Bernhardt, P, Johanson, V, Schmitt, A, Ahlman, H, Forssell-Aronsson, E, Mäcke, H, Nilsson, O
Publicado 2005

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck

por Kim, J G, Sohn, S K, Kim, D H, Baek, J H, Jeon, S B, Chae, Y S, Lee, K B, Park, J S, Sohn, J H, Kim, J C, Park, I K
Publicado 2005

Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ

por de Roos, M A J, de Bock, G H, Baas, P C, de Munck, L, Wiggers, T, de Vries, J
Publicado 2005

Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial

por Stathopoulos, G P, Dimitroulis, J, Antoniou, D, Katis, C, Tsavdaridis, D, Armenaki, O, Marosis, C, Michalopoulou, P, Grigoratou, T, Stathopoulos, J
Publicado 2005

Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3

por Hughes, S, Damato, B E, Giddings, I, Hiscott, P S, Humphreys, J, Houlston, R S
Publicado 2005

Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse

por Domingo-Domenech, J, Mellado, B, Ferrer, B, Truan, D, Codony-Servat, J, Sauleda, S, Alcover, J, Campo, E, Gascon, P, Rovira, A, Ross, J S, Fernández, P L, Albanell, J
Publicado 2005

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced soli...

por Siegel-Lakhai, W S, Crul, M, Zhang, S, Sparidans, R W, Pluim, D, Howes, A, Solanki, B, Beijnen, J H, Schellens, J H M
Publicado 2005

Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts

por Larsson, S C, Permert, J, Håkansson, N, Näslund, I, Bergkvist, L, Wolk, A
Publicado 2005

Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer

por Hackshaw, A, Knight, A, Barrett-Lee, P, Leonard, R
Publicado 2005